{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:31:05Z","timestamp":1782930665904,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2710-6","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T00:44:37Z","timestamp":1471567477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Connect MDS\/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study"],"prefix":"10.1186","volume":"16","author":[{"given":"David P.","family":"Steensma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medrdad","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Bejar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Cogle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Foucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Garcia-Manero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy I.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Grinblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Komrokji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Pollyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Savona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkael A.","family":"Sekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene S.","family":"Swern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Nifenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Sugrue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Erba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,19]]},"reference":[{"issue":"6","key":"2710_CR1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMp048266","volume":"352","author":"M Cazzola","year":"2005","unstructured":"Cazzola M, Malcovati L. Myelodysplastic syndromes--coping with ineffective hematopoiesis. N Engl J Med. 2005;352(6):536\u20138.","journal-title":"N Engl J Med"},{"issue":"7","key":"2710_CR2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.mayocp.2015.04.001","volume":"90","author":"DP Steensma","year":"2015","unstructured":"Steensma DP. Myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc. 2015;90(7):969\u201383.","journal-title":"Mayo Clin Proc"},{"key":"2710_CR3","doi-asserted-by":"crossref","unstructured":"Vardiman JW. Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2006;199\u2013204.","DOI":"10.1182\/asheducation-2006.1.199"},{"key":"2710_CR4","first-page":"1183","volume-title":"Williams hematology","author":"JL Liesveld","year":"2005","unstructured":"Liesveld JL, Lichtman MA. Acute myelogenous leukemia. In: Lichtman MA, editor. Williams hematology. 7th ed. New York: McGraw-Hill; 2005. p. 1183\u2013236.","edition":"7"},{"issue":"5","key":"2710_CR5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2141.2010.08470.x","volume":"152","author":"DA Pollyea","year":"2011","unstructured":"Pollyea DA, Kohrt HE, Medeiros BC. Acute myeloid leukaemia in the elderly: a review. Br J Haematol. 2011;152(5):524\u201342.","journal-title":"Br J Haematol"},{"issue":"5","key":"2710_CR6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937\u201351.","journal-title":"Blood"},{"issue":"7","key":"2710_CR7","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7):2292\u2013302.","journal-title":"Blood"},{"issue":"6","key":"2710_CR8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.leukres.2006.11.009","volume":"31","author":"P Valent","year":"2007","unstructured":"Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res. 2007;31(6):727\u201336.","journal-title":"Leuk Res"},{"issue":"1","key":"2710_CR9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126(1):9\u201316.","journal-title":"Blood"},{"issue":"3","key":"2710_CR10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11899-015-0270-5","volume":"10","author":"R Bejar","year":"2015","unstructured":"Bejar R. Myelodysplastic syndromes diagnosis: what is the role of molecular testing? Curr Hematol Malig Rep. 2015;10(3):282\u201391.","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"2710_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.leukres.2011.09.023","volume":"36","author":"P Valent","year":"2012","unstructured":"Valent P, Bain BJ, Bennett JM, Wimazal F, Sperr WR, Mufti G, et al. Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS. Leuk Res. 2012;36(1):1\u20135.","journal-title":"Leuk Res"},{"key":"2710_CR12","unstructured":"Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975\u20132012. Bethesda: National Cancer Institute. http:\/\/seer.cancer.gov\/csr\/1975_2012\/ , based on November 2014 SEER data submission, posted to the SEER web site, April 2015."},{"issue":"26","key":"2710_CR13","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1182\/blood-2011-02-337964","volume":"117","author":"CR Cogle","year":"2011","unstructured":"Cogle CR, Craig BM, Rollison DE, List AF. Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries. Blood. 2011;117(26):7121\u20135.","journal-title":"Blood"},{"issue":"18","key":"2710_CR14","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2014-04-522136","volume":"124","author":"R Bejar","year":"2014","unstructured":"Bejar R, Steensma DP. Recent developments in myelodysplastic syndromes. Blood. 2014;124(18):2793\u2013803.","journal-title":"Blood"},{"issue":"3","key":"2710_CR15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11899-015-0269-y","volume":"10","author":"CR Cogle","year":"2015","unstructured":"Cogle CR. Incidence and burden of the myelodysplastic syndromes. Curr Hematol Malig Rep. 2015;10(3):272\u201381.","journal-title":"Curr Hematol Malig Rep"},{"issue":"17","key":"2710_CR16","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1200\/JCO.2009.25.2395","volume":"28","author":"SL Goldberg","year":"2010","unstructured":"Goldberg SL, Chen E, Corral M, Guo A, Mody-Patel N, Pecora AL, et al. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. J Clin Oncol. 2010;28(17):2847\u201352.","journal-title":"J Clin Oncol"},{"key":"2710_CR17","volume-title":"NCCN clinical practice guidelines in oncology\u2122 myelodysplastic syndromes","author":"National Comprehensive Cancer Network","year":"2015","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology\u2122 myelodysplastic syndromes. 2015. Version 1.2016."},{"issue":"3","key":"2710_CR18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.leu.2405070","volume":"22","author":"G Garcia-Manero","year":"2008","unstructured":"Garcia-Manero G, Shan J, Faderl S, Cortes J, Ravandi F, Borthakur G, et al. A prognostic score for patients with lower risk myelodysplastic syndrome. Leukemia. 2008;22(3):538\u201343.","journal-title":"Leukemia"},{"issue":"12","key":"2710_CR19","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454\u201365.","journal-title":"Blood"},{"key":"2710_CR20","doi-asserted-by":"crossref","unstructured":"Nazha A, Narkhede MS, Radivoyevitch T, Kalaycio M, Patel BJ, Gerds AT, et al. The Revised International Prognostic Scoring System \u201cMolecular\u201d (IPSS-Rm), a Validated and Dynamic Model in Treated Patients with Myelodysplastic Syndromes (MDS). Blood. 2015;126(23). [ASH abstract 607].","DOI":"10.1182\/blood.V126.23.607.607"},{"key":"2710_CR21","volume-title":"NCCN clinical practice guidelines in oncology: acute myeloid leukemia","author":"National Comprehensive Cancer Network","year":"2015","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: acute myeloid leukemia. 2015. Version 1."},{"issue":"3","key":"2710_CR22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H Dohner","year":"2010","unstructured":"Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European Leukemia Network. Blood. 2010;115(3):453\u201374.","journal-title":"Blood"},{"issue":"17","key":"2710_CR23","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood-2013-03-492884","volume":"122","author":"L Malcovati","year":"2013","unstructured":"Malcovati L, Hellstrom-Lindberg E, Bowen D, Ades L, Cermak J, Del Canizo C, et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood. 2013;122(17):2943\u201364.","journal-title":"Blood"},{"issue":"24","key":"2710_CR24","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1200\/JCO.2014.55.1564","volume":"32","author":"HD Klepin","year":"2014","unstructured":"Klepin HD, Rao AV, Pardee TS. Acute myeloid leukemia and myelodysplastic syndromes in older adults. J Clin Oncol. 2014;32(24):2541\u201352.","journal-title":"J Clin Oncol"},{"issue":"11","key":"2710_CR25","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/cncr.28631","volume":"120","author":"DP Steensma","year":"2014","unstructured":"Steensma DP, Komrokji RS, Stone RM, List AF, Garcia-Manero G, Huber JM, et al. Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes. Cancer. 2014;120(11):1670\u20136.","journal-title":"Cancer"},{"issue":"5","key":"2710_CR26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2014-08-551499","volume":"125","author":"G Ossenkoppele","year":"2015","unstructured":"Ossenkoppele G, Lowenberg B. How I treat the older patient with acute myeloid leukemia. Blood. 2015;125(5):767\u201374.","journal-title":"Blood"},{"issue":"7","key":"2710_CR27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3324\/haematol.2013.087601","volume":"98","author":"A Cherubini","year":"2013","unstructured":"Cherubini A, Pierri F, Gasperini B, Zengarini E, Cerenzia A, Bonifacio E, et al. Are ongoing trials on hematologic malignancies still excluding older subjects? Haematologica. 2013;98(7):997\u20131000.","journal-title":"Haematologica"},{"issue":"6","key":"2710_CR28","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6):2079\u201388.","journal-title":"Blood"},{"issue":"15","key":"2710_CR29","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1002\/cncr.28129","volume":"119","author":"MS Thein","year":"2013","unstructured":"Thein MS, Ershler WB, Jemal A, Yates JW, Baer MR. Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades. Cancer. 2013;119(15):2720\u20137.","journal-title":"Cancer"},{"issue":"3 Suppl 2","key":"2710_CR30","first-page":"13","volume":"34","author":"D Cella","year":"1997","unstructured":"Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol. 1997;34(3 Suppl 2):13\u20139.","journal-title":"Semin Hematol"},{"issue":"5","key":"2710_CR31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337\u201343.","journal-title":"Ann Med"},{"issue":"11","key":"2710_CR32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.1997.03540350077040","volume":"277","author":"International Committee of Medical Journal Editors","year":"1997","unstructured":"International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. JAMA. 1997;277(11):927\u201334.","journal-title":"JAMA"},{"issue":"6","key":"2710_CR33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/M15-0288","volume":"163","author":"WP Battisti","year":"2015","unstructured":"Battisti WP, Wager E, Baltzer L, Bridges D, Cairns A, Carswell CI, et al. Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med. 2015;163(6):461\u20134.","journal-title":"Ann Intern Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2710-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T07:53:13Z","timestamp":1601020393000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2710-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,19]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2710"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2710-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,19]]},"article-number":"652"}}